CRISPR screen in patient-derived xenografts. A recent study by the Aceto lab at ETH Zurich identifies novel drivers and treatment opportunities for metastatic breast cancers. More: biol.ethz.ch/en/news-and-eve…

Dec 22, 2021 · 10:14 AM UTC

1